BridgeMD
Prevention study for Cardiovascular (CV) Risk
Official title Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model
ClinicalTrials.gov ID: NCT07608926
What this study is testing
- What it's testing
- Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 75
You may be able to join if
- Age between 40 and 75 years
- hypertension
- hyperglycaemia
- type 2 diabetes not requiring insulin therapy
- dyslipidaemia
You likely can't join if
- previous myocardial infarction
- stroke
- transient ischemic attack
- coronary artery diseas
- peripheral arterial occlusive disease
- heart failure
See the full eligibility criteria
- Age between 40 and 75 years
- hypertension
- hyperglycaemia
- type 2 diabetes not requiring insulin therapy
- dyslipidaemia
- active smoking
- overweight/grade I obesity
- Willingness to participate in follow-up visits over 24 months
- previous myocardial infarction
- stroke
- transient ischemic attack
- coronary artery diseas
- peripheral arterial occlusive disease
- heart failure
- Type 1 or type 2 diabetes mellitus on insulin therapy
- Advanced chronic kidney disease (eGFR \< 30 mL/min/1.73 m²)
- Active cancer disease
- Severe obesity
- Inability to use digital tools
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Cotignola, Ravenna, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cotignola, Ravenna, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.